NCT00231023View on ClinicalTrials.gov

Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

May 31, 2006

Conditions
Diabetic Retinopathy
Interventions
DRUG

Peribulbar Triamcinolone Acetonide

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00231023 - Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema | Biotech Hunter | Biotech Hunter